CLINICAL_TRIALS
trial_result
· 2021-04-21
Clinical Trial Update: Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy [Phase 2]
Summary
Phase 2 trial evaluating intravitreal aflibercept for retinal non-perfusion in proliferative diabetic retinopathy has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Charles C Wykoff, PhD, MD | Conditions: Proliferative Diabetic Retinopathy | Phase 2 | Status: COMPLETED | Results posted: 2021-04-21